SCHEMBL4812296

SCHEMBL4812296

CCOC(=O)CC(=O)Cc1ccc(Br)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 2/20 0.47
MAPK1 P28482 2/20 0.47
S1PR4 O95977 1/20 0.47
LMNA P02545 1/20 0.47
S1PR1 P21453 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYP4Z1 Q86W10 1/20 0.46
KDM4E B2RXH2 1/20 0.45
GLA P06280 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
POLB P06746 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15334365 0.86 GAA (0.52) KMT2AMAPTHPGDMEN1LMNA
SCHEMBL4733 0.86 CYP1A2 (0.55) KMT2AMAPTALDH1A1HPGDMEN1
SCHEMBL4077327 0.85 KMT2A (0.49) KMT2AMAPTLMNACYP4Z1MGAM
SCHEMBL7960432 0.84 L3MBTL1 (0.53) KMT2AALDH1A1HPGDMEN1LMNA
SCHEMBL15964601 0.84 KMT2A (0.49) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL622329 0.83 MAPT (0.61) KMT2AMAPTALDH1A1HPGDMEN1
SCHEMBL14390296 0.83 CYP4Z1 (0.46) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL21572817 0.83 CYP4Z1 (0.46) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL699965 0.83 KDM4E (0.50) KMT2AMAPTALDH1A1HPGDMEN1
SCHEMBL319873 0.83 PPID (0.54) KMT2AALDH1A1MEN1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3529250-B1 IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS H LUNDBECK AS (DK) 2023-12-06 EP disclosed
CN-111467346-B Pyridone derivatives with tetrahydropyranylmethyl groups 第一三共株式会社 2023-05-16 CN disclosed
CN-109843884-B Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors H.隆德贝克有限公司 2022-03-04 CN disclosed
US-20220002277-A1 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-01-06 US disclosed
US-11208403-B2 Pyridone derivatives having tetrahydropyranylmethyl groups DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-12-28 US disclosed
CN-110036014-B Compound with AXL inhibitory activity and preparation and application thereof 中国科学院上海药物研究所 2021-09-07 CN disclosed
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 US disclosed
EP-3168219-B1 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP DAIICHI SANKYO CO LTD (JP) 2021-03-31 EP disclosed
EP-3731840-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF Orfan Biotech Inc. (US) 2020-11-04 EP disclosed
CN-111467346-A Pyridone derivatives with tetrahydropyranylmethyl groups 第一三共株式会社 2020-07-31 CN disclosed
EP-1349843-B1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-04-20 EP disclosed
US-20040072838-A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION 2004-04-15 US disclosed
EP-1349843-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2003-10-08 EP disclosed
WO-2002059098-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2002-08-01 WO disclosed
US-5827863-A Pyrazole derivatives as angiotensin II antagonists J. URIACH & CIA, S.A. (ES) 1998-10-27 US disclosed
US-5712296-A Substituted pyridines and 2-oxo-1,2-dihydropyridines BAYER AKTIENGESELLSCHAFT (DE) 1998-01-27 US disclosed
EP-0721454-A1 NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST J. URIACH & CIA. S.A. (ES) 1996-07-17 EP disclosed
US-5492923-A DRUG FOR TREATING ARTERIAL HYPERTENSION AND ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-02-20 US disclosed
WO-1996004273-A1 NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST J. URIACH & CIA, S.A. (ES) 1996-02-15 WO disclosed
EP-0623610-A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines as Angiotensine II antagonists BAYER AG (DE) 1994-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002277-A1 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP AXL, TYRO3, LCK KMT2A 2465/4885MAPT 2529/4885ALDH1A1 4480/4885
US-20040072838-A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors PPARA, PPARG, PPARD KMT2A 3950/4885MAPT 4132/4885ALDH1A1 1168/4885
US-11208403-B2 Pyridone derivatives having tetrahydropyranylmethyl groups AXL, TYRO3, PDXK KMT2A 2843/4885MAPT 2654/4885ALDH1A1 4318/4885
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS KMT2A 3407/4885MAPT 2376/4885ALDH1A1 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.